Sclerostin is a 22.5 kDa secreted glycoprotein that functions as a potent inhibitor of Wnt signaling. It acts by binding to the Wnt-coreceptor LRP5/6 thus inhibiting bone formation by regulating osteoblast function and promoting osteoblast apoptosis. The Sclerostin protein consists of two flexible N- and C-terminal arms and a cystine-knot with three loops, whereas the second loop binds to the LRP5/6 complex. Sclerostin is classically considered to be a monomeric protein, but data from Hernandez and colleagues (Hernandez et al., 2014) postulate that circulating sclerostin has a dimeric configuration. In addition, it is not yet well documented if also Sclerostin fragments circulate, but the comparison of different Sclerostin ELISAs suggest that fragments exist as well (Dallas et al., 2013).
產(chǎn)品描述
Method
Sandwich ELISA, HRP/TMB, 12×8-well detachable strips
Sample type
Serum, EDTA plasma, citrate plasma, hepar?n plasma, urine, cell culture supernatant
Sample volume
20 μl / well
Assay time
18-24 h / 1 h / 30 min
Sensitivity
3.2 pmol/l (= 72 pg/ml)
Standard range
0 – 240 pmol/l (= 0 – 5,400 pg/ml)
Conversion factor
1 pmol/l = 22.5 pg/ml (MW: 22.5 kDa)
Precision
In-between-run (n=6): ≤ 10 % CV
Within-run (n=8): ≤ 7 % CV
Specificity
Endogenous and recombinant human Sclerostin.
Cross-reactivity
The assay does not cross-react with Wise (Sostdc1) or Noggin. The assay does not cross-react with rat or mouse Sclerostin.